Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiretroviral Agents”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00000899
What this trial is testing

A Study on the Effect of Chemotherapy Combined With Anti-HIV Drugs in HIV-Positive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 10
Testing effectiveness (Phase 2)Ended earlyNCT04840199
What this trial is testing

Evaluate the Anti-inflammatory Effects of Letermovir (Prevymis) in Adults With Human Immunodeficiency Virus (HIV)-1 and Asymptomatic Cytomegalovirus (CMV) Who Are on Suppressive Antiretroviral Therapy, Plus Its Effect on Chronic Inflammation, HIV Persistence and Other Clinical Outcomes.

Who this might be right for
HIV InfectionsCytomegalovirusCMV
National Institute of Allergy and Infectious Diseases (NIAID) 44
Large-scale testing (Phase 3)Ended earlyNCT01923311
What this trial is testing

Two Part Study to Evaluate Pharmacokinetics, Safety, and Antiviral Activity of Elvitegravir Administered With a PI/r Background Regimen for ARV Treatment-Experienced Pediatric Participants

Who this might be right for
Acquired Immune Deficiency Syndrome (AIDS)HIV Infections
Gilead Sciences 31
Post-approval studies (Phase 4)Study completedNCT00647244
What this trial is testing

Efficacy and Safety of Switching From Retrovir to Tenofovir or Abacavir in HIV-infected Patients

Who this might be right for
HIV Infections
Aarhus University Hospital 40
Large-scale testing (Phase 3)Study completedNCT00013611
What this trial is testing

Interleukin-2 Plus Antiretroviral Therapy for HIV-Infected Patients With Low CD4+ Counts (SILCAAT Study)

Who this might be right for
HIV Infection
University of Minnesota 1,695
Large-scale testing (Phase 3)Study completedNCT00860977
What this trial is testing

Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals?

Who this might be right for
HIV InfectionHerpes Simplex Type IIHIV Infections
University Health Network, Toronto 202
Not applicableStudy completedNCT03800381
What this trial is testing

Adequacy of the New Pediatric Isoniazid/Rifampin/Pyrazinamide (HRZ) Tablet

Who this might be right for
TuberculosisHuman Immunodeficiency VirusCoinfection
University of Florida 92
Post-approval studies (Phase 4)Ended earlyNCT01791465
What this trial is testing

Pilot Study of Bydureon to Treat Diabetes in HIV-infected Adults

Who this might be right for
Human Immunodeficiency Virus InfectionDiabetes Mellitus
Vanderbilt University 6
Testing effectiveness (Phase 2)Study completedNCT01627678
What this trial is testing

Immunotherapy With Vacc-C5 With Adjuvant GM-CSF or Alhydrogel in HIV-1-infected Subjects on ART

Who this might be right for
HIV-1 Infection
Bionor Immuno AS 36
Large-scale testing (Phase 3)Study completedNCT01348308
What this trial is testing

Immuno-stimulation With Maraviroc Combined to Antiretroviral Therapy in Advanced Late Diagnosed HIV-1 Infected Patients

Who this might be right for
HIV-1 InfectionAIDS
ANRS, Emerging Infectious Diseases 407
Not applicableStudy completedNCT01976715
What this trial is testing

Study of People With HIV Infection Who Have High Viral Loads Despite Combination Antiretroviral Therapy

Who this might be right for
Acquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome VirusAIDS Virus+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 26
Not applicableUnknownNCT00247143
What this trial is testing

High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disease

Who this might be right for
HIVAIDS
Lampiris, Harry W., M.D. 20
Not applicableStudy completedNCT01797367
What this trial is testing

Pulmonary Substudy: A Substudy of Strategic Timing of AntiRetroviral Treatment (START)

Who this might be right for
Chronic Obstructive Pulmonary DiseaseHIV
University of Minnesota 1,026
Large-scale testing (Phase 3)Study completedNCT02707601
What this trial is testing

Efficacy, Safety, and Tolerability of Ledipasvir/Sofosbuvir (LDV/SOF) Treatment for HIV/HCV Co-infected Participants Who Switch to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) or Emtricitabine/Rilpivirine/Tenofovir Alafenamide (F/R/TAF) Prior to LDV/SOF HCV Treatment

Who this might be right for
HIV-1 InfectionHCV Infection
Gilead Sciences 150
Early research (Phase 1)Study completedNCT05850728
What this trial is testing

First in Human Study of TLC-ART 101 (ACTU 2001)

Who this might be right for
Human Immunodeficiency VirusTreatmentAntiretroviral Therapy
University of Washington 12
Testing effectiveness (Phase 2)Study completedNCT03041012
What this trial is testing

Early Administration of Romidepsin and 3BNC117 in Treatment-naïve HIV Patients Starting ART

Who this might be right for
Hiv
Aarhus University Hospital 60
Not applicableStudy completedNCT01957865
What this trial is testing

Real-Time Antiretroviral Therapy Adherence Intervention in Uganda

Who this might be right for
HIV/AIDSAdherence
Massachusetts General Hospital 63
Not applicableStudy completedNCT04418076
What this trial is testing

Project SMART Automated Pillbox Study

Who this might be right for
HIV/AIDSCocaine Use
Yale University 78
Post-approval studies (Phase 4)Study completedNCT01087840
What this trial is testing

Raltegravir Use as Nonoccupational Postexposure Prophylaxis (NPEP) in Men Who Have Sex With Men

Who this might be right for
HIV PreventionHIV Infections
Andrew Carr 120
Large-scale testing (Phase 3)Study completedNCT00002389
What this trial is testing

The Safety and Effectiveness of Lamivudine Plus Zidovudine, Used With and Without 1592U89, in HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
Glaxo Wellcome 210
Next Page